CRISPR Technology: Transforming Global Markets And Our Future

2025-01-02 02:31:04

(MENAFN- PR Newswire)

"CRISPR is a gene-editing tool that makes precise DNA changes, advancing drug development, crop improvement, and disease research. It opens new business opportunities and offers solutions for genetic diseases and sustainable agriculture. "

BOSTON, Jan. 2, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the demand for CRISPR Technology: Global Markets
was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029 at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

This report on CRISPR technology offers market predictions through 2029, examining how CRISPR is used across different fields like drug development, agriculture and diagnostics. It also looks at the users of CRISPR, including biotech and pharmaceutical companies, universities, government research institutes, and contract research organizations.

Interesting facts:

With
Casegvy's approval in late 2023, the CRISPR market is set to grow, particularly in drug development for genetic and chronic diseases. Biotech and pharma companies are driving this growth, supported by collaborations and rising private funding for innovation and expanded CRISPR use.

Factors contributing to the market's growth include:

Rising incidence of chronic diseases : The rise in chronic diseases like diabetes, heart disease, and arthritis is due to factors such as poor diet, lack of exercise, smoking, and longer lifespans. This increase is driving a greater demand for better healthcare to manage these long-term conditions.

High prevalence of genetic disorders:
The prevalence of genetic disorders, caused by changes in DNA, means that more people require specialized medical care. These disorders can be inherited or occur spontaneously.

Government and private funding.:
Government and private funding support R&D across various fields, driving innovation and progress. This financial support is crucial for achieving breakthroughs in areas like healthcare and technology.

Request a Sample Copy of
the CRISPR Technology: Global Markets Reports

Report Synopsis

Report Metric	Details
Base year considered	2023
Forecast period considered	2024-2029
Base year market size	$3.4 billion
Market size forecast	$7.5 billion
Growth rate	CAGR of 14.4% from 2024 to 2029
Segments covered	Application, End User, and Region
Regions covered	North America, Europe, Asia-Pacific and the Rest of the World (RoW)
Countries covered	U.S., Canada, Germany, United Kingdom, France, Japan, China and India
Market drivers	Rising incidence of chronic diseases. High prevalence of genetic disorders. Government and private funding.

This report addresses the following key questions:

What is the projected size and growth rate of the
CRISPR technology market?
The global
CRISPR technology market is expected to grow at a compound annual growth rate (CAGR) of 14.4% to reach $7.5 billion by the end of 2029, up from $3.8 billion in 2024.

What are the key factors driving the growth of the
CRISPR technology market?
These Include the rising incidence of chronic diseases, the high prevalence of genetic disorders, and growing government and private funding.

Which market segments are covered in the
CRISPR technology report?
The CRISPR technology market is segmented based on application, end user, and region.

Which application segment will dominate the market in 2029?
The drug development segment will dominate the market in 2029.

Which region has the highest share of the
CRISPR technology market?
North America holds the highest share of the market.

Leading companies in the market include:

Agilent Technologies Inc.
Beam Therapeutics
Caribou Biosciences Inc.
Crispr Therapeutics
Danaher Corp.
Editas Medicine
Genscript
Intellia Therapeutics Inc.
Lonza
Merck
KGaA
Thermo Fisher Scientific Inc.

Related reports include:

Induced Pluripotent Stem Cells : Induced pluripotent stem cells (iPSCs) are adult cells reprogrammed to act like embryonic stem cells. They can develop into any cell type, making them useful for research, drug testing, and disease treatments, without the ethical issues of using embryonic cells.

Directly Purchase a copy of the report
from BCC Research.

For further information on these reports or to purchase one, please get contact [email protected] .

About BCC Research
BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help readers make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA

Email: [email protected]

Phone: +1 781-489-7301

For media inquiries, email [email protected] or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo -

SOURCE BCC Research LLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN02012025003732001241ID1109050089

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.